chr11-110247798-A-G

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1

The NM_002906.4(RDX):ā€‹c.995T>Cā€‹(p.Ile332Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000104 in 1,590,720 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.000033 ( 0 hom., cov: 32)
Exomes š‘“: 0.00011 ( 1 hom. )

Consequence

RDX
NM_002906.4 missense

Scores

1
1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 2.91
Variant links:
Genes affected
RDX (HGNC:9944): (radixin) Radixin is a cytoskeletal protein that may be important in linking actin to the plasma membrane. It is highly similar in sequence to both ezrin and moesin. The radixin gene has been localized by fluorescence in situ hybridization to 11q23. A truncated version representing a pseudogene (RDXP2) was assigned to Xp21.3. Another pseudogene that seemed to lack introns (RDXP1) was mapped to 11p by Southern and PCR analyses. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.020410866).
BP6
Variant 11-110247798-A-G is Benign according to our data. Variant chr11-110247798-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 229200.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=2}.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.0000329 (5/151966) while in subpopulation SAS AF= 0.000626 (3/4794). AF 95% confidence interval is 0.00017. There are 0 homozygotes in gnomad4. There are 3 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RDXNM_002906.4 linkuse as main transcriptc.995T>C p.Ile332Thr missense_variant 10/14 ENST00000645495.2 NP_002897.1 P35241-1B0YJ88Q6PKD3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RDXENST00000645495.2 linkuse as main transcriptc.995T>C p.Ile332Thr missense_variant 10/14 NM_002906.4 ENSP00000496503.2 P35241-1

Frequencies

GnomAD3 genomes
AF:
0.0000329
AC:
5
AN:
151850
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000625
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000210
AC:
45
AN:
214444
Hom.:
1
AF XY:
0.000294
AC XY:
34
AN XY:
115714
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000327
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00136
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000441
Gnomad OTH exome
AF:
0.000358
GnomAD4 exome
AF:
0.000112
AC:
161
AN:
1438754
Hom.:
1
Cov.:
31
AF XY:
0.000150
AC XY:
107
AN XY:
714178
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000241
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00109
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000473
Gnomad4 OTH exome
AF:
0.000236
GnomAD4 genome
AF:
0.0000329
AC:
5
AN:
151966
Hom.:
0
Cov.:
32
AF XY:
0.0000404
AC XY:
3
AN XY:
74298
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000626
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000422
Hom.:
0
Bravo
AF:
0.0000227
ExAC
AF:
0.000199
AC:
24

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJun 01, 2022- -
Likely benign, criteria provided, single submitterclinical testingGeneDxOct 20, 2020- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineSep 08, 2015Variant classified as Uncertain Significance - Favor Benign. The p.Ile332Thr var iant in RDX has not been previously reported in individuals with hearing loss, b ut has been identified in 0.1% (17/11458) of South Asian chromosomes by the Exom e Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs53310716 4). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Computational prediction tool s and conservation analysis suggest that the p.Ile332Thr variant may not impact the protein, though this information is not predictive enough to rule out pathog enicity. In summary, while the clinical significance of the p.Ile332Thr variant is uncertain, its frequency in the general population and computational analyses suggest that it is more likely to be benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
22
DANN
Benign
0.74
DEOGEN2
Benign
0.12
.;.;.;T;.;T
Eigen
Benign
-0.38
Eigen_PC
Benign
-0.11
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.77
.;.;T;.;T;T
M_CAP
Benign
0.0083
T
MetaRNN
Benign
0.020
T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.49
N;N;N;N;.;N
PrimateAI
Pathogenic
0.81
D
PROVEAN
Benign
0.43
N;.;N;N;N;.
REVEL
Benign
0.074
Sift
Benign
0.51
T;.;T;T;T;.
Sift4G
Benign
0.57
T;.;T;T;T;.
Polyphen
0.0
.;.;.;B;.;B
Vest4
0.36
MutPred
0.34
Gain of phosphorylation at I332 (P = 6e-04);Gain of phosphorylation at I332 (P = 6e-04);Gain of phosphorylation at I332 (P = 6e-04);Gain of phosphorylation at I332 (P = 6e-04);.;Gain of phosphorylation at I332 (P = 6e-04);
MVP
0.30
MPC
0.21
ClinPred
0.062
T
GERP RS
5.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.095
gMVP
0.45

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs533107164; hg19: chr11-110118523; API